Absci outlines ABS-201 interim 13-week data in H2 2026 while adding ABS-202 and funding plans into H1 2028
Source: SeekingAlpha
2026-05-08 08:02:12 ET
More on Absci
- Absci Corporation (ABSI) Q1 2026 Earnings Call Transcript
- Absci Corporation (ABSI) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
- Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201
- Absci GAAP EPS of -$0.19 beats by $0.01, revenue of $0.2M misses by $1.21M
- Absci Q1 2026 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Absci outlines ABS-201 interim 13-week data in H2 2026 while adding ABS-202 and funding plans into H1 2028
Absci Corporation
NASDAQ: ABSI
ABSI Trading
22.16% G/L:
$7.085 Last:
5,240,234 Volume:
$5.99 Open:
ABSI Latest News
May 07, 2026 04:05:00 pm
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
April 23, 2026 04:05:00 pm
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
ABSI Stock Data
$396,980,842
134,597,557
0.04%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
Vancouver
